首页> 外文OA文献 >Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer

【2h】

Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer

机译：血清胸苷激酶1动力学在新乳腺癌期间血清胸苷激酶1动力学的预后作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
A. Matikas; K. Wang; E. Lagoudaki; B. Acs; I. Zerdes; J. Hartman; E. Azavedo; J. Bjöhle; L. Carlsson; Z. Einbeigi; I. Hedenfalk; M. Hellström; T. Lekberg; N. Loman; A. Saracco; A. von Wachenfeldt; S. Rotstein; M. Bergqvist; J. Bergh; T. Hatschek; T. Foukakis;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT) [J] . McCartney Amelia, Biagioni Chiara, Schiavon Gaia, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2019,第期

机译：激素受体阳性转移性乳腺癌患者血清胸苷激酶1活性的预后作用：对Faslodex的随机阶段III评价分析与长期临床试验（EFECT）
2. Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume [J] . Bernhard Tribukait BMC Cancer . 2020,第1期

机译：早期预测乳腺癌新辅助治疗的病理反应：基于血清胸苷激酶1和肿瘤体积的细胞损失度量
3. Serum thymidine kinase-1 activity (TKa) as a prognostic marker in premenopausal women with hormone receptor positive (HR plus ) operable breast cancer (BC) [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：血清胸苷激酶-1活性（TKA）作为具有激素受体阳性（HR加）可操作乳腺癌（BC）的前辈妇女的预后标志物
4. Prognostic Significance of COX-2 and VEGF in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy [C] . Gang-Ping WANG, Xue WANG, Zhao-Jun DING, International Conference on Biological Sciences and Technology . 2016

机译：Cox-2和VEGF在接受新辅助化疗的乳腺癌患者中的预后意义
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer [O] . A. Matikas, K. Wang, E. Lagoudaki, 2021

机译：血清胸苷激酶1动力学在新乳腺癌期间血清胸苷激酶1动力学的预后作用
7. Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume [O] . Bernhard Tribukait 2020

机译：早期预测乳腺癌新辅助治疗的病理反应：基于血清胸苷激酶1和肿瘤体积的细胞损失度量

Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅